RSHO™ Receives Shelf Stability Approval By Denver Public Health Department

Medical Marijuana, Inc.’s HempMedsRSHO Receives Shelf Stability Approval By Denver Public Health Department
HempMedsFlagship Product, Real Scientific Hemp Oil(RSHO) Qualifies for Potentially Non-Hazardous FoodHandling

San Diego, CA – June 3, 2015 – Medical Marijuana, Inc. (OTC Pink: MJNA) is proud to announce to the public and shareholders that its portfolio Company, HempMeds™, received authorization from the Denver Public Health Department that Real Scientific Hemp Oil™ (RSHO™) Blue and Gold hemp oil brands (both 3- and 10-gram oral syringe tubes) qualified for “potentially non-hazardous foods not requiring time or temperature control”. To follow protocol, HempMeds™ will provide a copy of the letter with RSHO™ shipments to Denver-area retailers.

“HempMeds sincerely appreciates the efforts of the City of Denver, Colorado, in recognizing HempMeds’ flagship RSHO as a food product,” states Marcos Agramont, Operations Manager at HempMeds™. “As a result of the Company’s efforts with packaging RSHO and stability of the product, the City of Denver agrees that no refrigeration is needed for on-shelf display of unopened tubes. This allows HempMeds’ authorized retailers the ability to prominently promote RSHO on shelves versus in a potentially limited refrigerated display environment. With this certification, HempMeds is looking forward to providing RSHO to more hemp and cannabis retailers in the Denver area.”

At Medical Marijuana, Inc. product quality and safety are of the utmost importance to protect the reputation of their company, portfolio investments, brands and customers. While not a requirement, the Company mandates that their hemp oil is tested by two of the top food and cannabis testing laboratories in the country. Laboratory qualifications include:

  • A2LA: ISO/IEC 17025
  • FSIS approved laboratories
  • AMS approved laboratory
  • VASP approved laboratory
  • USDA accredited laboratory
  • ASTA check sample program
  • ISO accredited for mandatory nutritional analyses

“Every batch of hemp oil sourced by Medical Marijuana, Inc. and their portfolio companies are tested separately at these industry-renowned laboratories. Each batch number is then matched, results are

reviewed and approved. Only then will production of finished products commence. Should there ever be any question between the independently issued results, MJNA and/or its portfolio Company’s policy is to not produce finished products until the discrepancy is resolved. These reports are extremely detailed and may be requested through the Company,” states Andrew Hard, spokesperson for HempMeds.

In recent news, HempMeds’ RSHO™ has made significant progress in public awareness. Most notably, with the acceptance of RSHO™ hemp oil products in Brazil. There, an historic change occurred in the country’s cannabis law permitting RSHO™ for import, through HempMeds Brasil™.

On June 1, Texas became the 15th state with a “low THC cannabis” (also known as “CBD-only”) law signed into effect by Gov. Greg Abbott. In response to the legislation, news features by CBS and Unvision in Dallas, Texas, highlighted the use of RSHO™ as a readily available alternative product in all 50 states by a local mother on behalf of her five-year-old daughter with special needs (details at

For more information on HempMeds™ and their all-natural CBD hemp oil products, visit: The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds™ through the Company’s social media websites on Facebook and Twitter.

About HempMeds Brasil and LLC HempMeds PX, LLC HempMeds® is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink: MJNA) and is its exclusive distributor of RSHO™. HempMeds Brasil™ offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil. For more information on HempMeds Brasil™ and their all-natural hemp oil products, visit: The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds Brasil™ through the Company’s social media channels Facebook, Twitter and blog.

About Medical Marijuana Inc. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:

FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of

the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Public Relations contact:

Andrew Hard Spokesperson CMW Media P. 858-380-5478 [email protected]

Corporate contact:

Medical Marijuana, Inc.

Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations: GH Investment Advisors 550 West “C” Street, Ste. 2040 San Diego, CA 92101 Nick Massalas Office: (858) 264-6500 Toll Free: (877) 964-6463 [email protected]

# # #